Noble Corporation PLC (NE) Stock News

Rosen Law Firm announces a July 28, 2026 deadline for investors to join a securities class action against Lucid Group, Inc. The lawsuit alleges that Lucid made false statements regarding supplier quality issues that disrupted Gravity deliveries and overstated manufacturing capabilities, resulting in material negative impact on the company's business and financial results.

Rosen Law Firm is notifying Phreesia, Inc. investors who purchased stock between May 8, 2025 and March 30, 2026 of an important July 13, 2026 deadline to serve as lead plaintiff in a securities class action. The lawsuit alleges that Phreesia made false statements and concealed material facts regarding slowing demand and weakened pharmaceutical marketing commitments in its Network Solutions segment, resulting in investor damages.

A securities class action lawsuit has been filed against Zoetis Inc. for allegedly making false and misleading statements about its Companion Animal products during January 14, 2025 to May 6, 2026. The lawsuit claims the company failed to disclose weakening veterinarian adoption of its Librela pain treatment following FDA safety warnings, significant market share losses in Simparica Trio to competitors, and declining market share in dermatology products Apoquel and Cytopoint. Investors with losses exceeding $100,000 are encouraged to join the class action before the July 27, 2026 lead plaintiff deadline.

Rosen Law Firm is notifying investors in Calix, Inc., Erasca, Inc., and Graphic Packaging Holding Company of ongoing securities class action lawsuits. The firm is seeking lead plaintiffs with a July 27, 2026 deadline. Calix investors are accused of making false statements regarding profit margins related to memory component purchasing, while the firm encourages investors with losses exceeding $100,000 to seek legal counsel.

InnSuites Hospitality Trust (IHT) reported Fiscal Q1 2027 net income of $74,702, a $35,672 improvement year-over-year, with record hotel revenue of $2.2 million and combined occupancy reaching 85.37%. The company continues exploring diversification opportunities including a potential reverse merger, IBC Hotels independent hotel services, and investments in UniGen Power's clean energy technology.

Rosen Law Firm has filed securities class action lawsuits against Graphic Packaging Holding Company, Sportradar Group AG, and FS KKR Capital Corp., alleging that defendants made false or misleading statements regarding their financial performance and business conditions. Investors with losses exceeding $100,000 are encouraged to join the class actions before the July 6, 2026 lead plaintiff deadline.

A class action lawsuit has been filed against Veritone, Inc. for allegedly making false statements and failing to disclose inaccurate revenue recording, misclassified costs, overstated financial metrics, and deficient internal controls. Investors who purchased Veritone securities between October 14, 2025 and April 14, 2026 have until July 20, 2026 to apply as lead plaintiff.

Rosen Law Firm has issued multiple securities class action deadline alerts for investors. The primary case involves Sportradar Group AG (SRAD), where investors who purchased shares between November 7, 2024 and April 21, 2026 may be entitled to compensation. The lawsuit alleges that Sportradar made false statements about compliance and worked with black-market gambling operators while claiming strict regulatory adherence. The lead plaintiff deadline is July 17, 2026. Similar deadline alerts were also issued for FS KKR Capital Corp. (FSK) and Regencell Bioscience Holdings Limited (RGC).

Via Transportation, Inc. faces a class action lawsuit alleging its September 2025 IPO offering documents were materially false and misleading. The company allegedly concealed declining revenue per customer and regulatory issues in Germany. Stock has dropped approximately 70% below the IPO price of $46 following successive negative earnings announcements. Investors with substantial losses have until August 10, 2026 to seek lead plaintiff status.

Preformed Line Products (NASDAQ: PLPC) announced a regular quarterly dividend of $0.21 per share, payable on July 20, 2026, to shareholders of record as of July 1, 2026. The dividend was declared by the company's Board of Directors on June 6, 2026.

Rosen Law Firm is reminding investors in Regencell Bioscience Holdings Limited (RGC) and AeroVironment, Inc. (AVAV) of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege that defendants made false or misleading statements regarding market manipulation vulnerabilities, regulatory risks, and financial exposure during their respective class periods.

Class action lawsuits have been filed against BitGo Holdings, Erasca, Nano-X Imaging, and Microsoft Corporation, alleging that defendants made materially false and misleading statements and failed to disclose material adverse facts about their businesses. Investors have until August 7-11, 2026 to file lead plaintiff motions.

Rosen Law Firm has filed a securities class action lawsuit against SES AI Corporation, alleging the company made materially false and misleading statements about business prospects, overstated deal results, created artificial revenue through circular transactions, and failed to disclose material logistics constraints affecting 2025-2026 revenues. Investors with losses exceeding $100K are encouraged to join the class action before the June 26, 2026 deadline.

Rosen Law Firm has filed a securities class action lawsuit against POET Technologies Inc. for allegedly making false and misleading statements regarding its tax status as a potential passive foreign investment company (PFIC), failing to disclose negative tax implications for U.S. stockholders, and an executive's violation of a non-disclosure agreement. Investors with losses exceeding $100,000 are encouraged to join the class action before the June 29, 2026 deadline.

Investor rights law firm Halper Sadeh LLC is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers.

Capital Link Shipping has expanded its maritime intelligence platform with new executive discussions from leading shipping companies including Scorpio Tankers, DHT Holdings, d'Amico International Shipping, and others. The platform provides market insights on tanker and dry bulk sectors, featuring CEO perspectives on market developments, company strategies, and capital markets trends.

Rosen Law Firm is notifying investors in FS KKR Capital Corp. (FSK) of a securities class action lawsuit covering the period from May 8, 2024 to February 25, 2026. The lawsuit alleges that the company made false or misleading statements regarding portfolio restructuring effectiveness, investment valuations, and distribution strategy durability. Investors have until July 6, 2026 to serve as lead plaintiff.

Rosen Law Firm announces securities class action lawsuits against Regencell Bioscience Holdings Limited, Sportradar Group AG, and TruBridge, Inc. Investors with losses exceeding $100,000 are encouraged to join the litigation before the June 23, 2026 deadline. The lawsuits allege false and misleading statements regarding market manipulation, regulatory risks, and undisclosed material information.

GO Residential REIT completed acquisitions of 7 Dey Street in Tribeca and Ivy Tower in Times Square, increasing its portfolio to 2,545 residential suites (26% growth). The transactions are expected to be immediately accretive to AFFO per unit and were funded through available cash and $146.3 million in fixed-rate mortgage debt at 4.50%. The REIT approved a monthly cash distribution of $0.05325 per unit for June 2026.

Badger Meter, Inc. (NYSE: BMI) faces a securities class action lawsuit alleging executives knew about short-cycle demand variability but misrepresented it to investors as 'robust' demand between April 2024 and April 2026. The company's stock plummeted 24% on April 17, 2026, after finally disclosing softer municipal customer ordering. Shareholders lost over $95 per share cumulatively. The lawsuit contends management pulled forward customer orders to inflate financial results while concealing the practice from investors.

Law Offices of Howard G. Smith announced securities fraud class action lawsuits against four publicly-traded companies. Phreesia Inc. faces allegations of misrepresenting growth projections, Sportradar Group AG is accused of working with black-market gambling operators while claiming compliance, Commvault Systems Inc. allegedly failed to properly account for sales type impacts on ARR growth, and Veritone Inc. is charged with revenue misclassification and deficient internal controls. Investors have until mid-July 2026 to file lead plaintiff motions.

MOUNT GILEAD, N.C. , June 15, 2026 /PRNewswire/ -- McRae Industries, Inc. (Pink Sheets: MCRAA and MCRAB) reported consolidated net revenues for the third quarter of fiscal 2026 of $27,418,000 as compared to $30,870,000 for the third quarter of fiscal 2025. Net earnings for the third quarter of fiscal 2026 amounted to $858,000, or $0.38 per diluted Class A common share, as compared to $3,160,000, or $1.40 per diluted Class A common share, for the third quarter of fiscal 2025. Consolidated net revenues for the first nine months of fiscal 2026 totaled $86,569,000 as compared to $87,120,000 for the first nine months of fiscal 2025. Net earnings for the first nine months of fiscal 2026 amounted to $3,262,000, or $1.45 per diluted Class A common share, as compared to net earnings of $6,059,000, or $2.68 per diluted Class A common share, for the first nine months of fiscal 2025. THIRD QUARTER FISCAL 2026 COMPARED TO THIRD QUARTER FISCAL 2025 Consolidated net revenues totaled $27.4 million for the third quarter of fiscal 2026 as compared to $30.9 million for the third quarter of fiscal 2025. Sales related to our western/lifestyle boot products for the third quarter of fiscal 2026 totaled $19.7 million as compared to $20.2 million for the third quarter of fiscal 2025. This decrease in net revenues was mainly driven by a decrease in our Laredo brand. Revenues from our work boot products decreased from $8.7 million for the third quarter of fiscal 2025 to $7.9 million for the third quarter of fiscal 2026. This was primarily a result of decreased orders on military boots. Additionally, third quarter revenues for fiscal 2025 included $2.0 million in land sales through our affiliate American Mortgage Investment Company (AMIC). Consolidated gross profit for the third quarter of fiscal 2026 amounted to approximately $6.9 million as compared to $9.8 million for the third quarter of fis

Aurion Resources Ltd. has successfully completed its plan of arrangement with Agnico Eagle Mines Limited, whereby Agnico acquired all outstanding common shares of Aurion for C$2.60 per share in cash. Following the completion, Aurion Shares will be delisted from the TSX Venture Exchange and Aurion will cease to be a reporting issuer under Canadian securities laws.

Worldline has completed a 40-to-1 reverse share split, reducing outstanding shares from 2.26 billion to 56.59 million with a new par value of €0.80. The company automatically adjusted conversion ratios for convertible bonds (OCEANEs), stock options, and performance/free share allocations to preserve holder rights. Trading of new shares began on June 15, 2026 under new ISIN code FR00140182K6.

Worldline has completed a stock consolidation on June 15, 2026, exchanging 40 old shares (€0.02 par value) for 1 new share (€0.80 par value). The operation reduces outstanding shares from 2.26 billion to 56.59 million while maintaining total capital unchanged. Mechanical adjustments were made to convertible bonds (OCEANEs), stock options, and performance/free share plans to preserve holders' rights.

Rosen Law Firm has filed a securities class action lawsuit against POET Technologies Inc. for allegedly making false and misleading statements regarding its tax status as a potential passive foreign investment company (PFIC), failing to disclose negative tax implications for U.S. stockholders, and an executive's violation of a non-disclosure agreement. Investors who purchased POET securities between April 1, 2026 and April 27, 2026 may be eligible to join the class action with a lead plaintiff deadline of June 29, 2026.

Rosen Law Firm has filed class action lawsuits against BitGo Holdings, GeneDx Holdings, and Via Transportation on behalf of investors. The BitGo lawsuit alleges that offering documents contained materially false statements regarding the company's assessment of risks posed by declining digital asset prices to its business and financial performance. Investors who purchased securities during specified periods may be eligible for compensation.

Rosen Law Firm has filed a class action lawsuit against GeneDx Holdings Corp. on behalf of investors who purchased common stock between April 16, 2025 and May 4, 2026. The lawsuit alleges that GeneDx made false statements regarding the Fabric acquisition's positive impact on the company's financials and operational efficiencies, while knowingly concealing significant viability problems that would negatively affect the business. Investors who suffered losses may be eligible for compensation.

Rosen Law Firm has filed a securities class action lawsuit against SES AI Corporation on behalf of investors who purchased securities between January 29, 2025 and March 4, 2026. The lawsuit alleges that SES AI made materially false and misleading statements regarding business prospects, overstated expected results from business deals, artificially created revenue appearances, and failed to disclose material logistics constraints that affected Q4 2025 revenues and 2026 guidance. The lead plaintiff deadline is June 26, 2026.

Menarini Group and Stemline Therapeutics announced positive Phase 3 SENTRY trial results showing that selinexor combined with ruxolitinib met the primary endpoint for spleen volume reduction (SVR35) at 49.8% versus 28% for ruxolitinib alone in myelofibrosis patients. The combination also demonstrated a promising early overall survival signal with greater than 50% reduction in death risk, though it did not meet the secondary symptom score endpoint. The safety profile was manageable with no new safety signals observed.